Imaging Study Outlines Neural Response to Criticism from a Third-Party Perspective
Criticism perceived in an individual’s own environment may influence the response to criticism from a third-party perspective.
General Psychiatry
FDA Committees Vote on Novel Therapy for Schizophrenia, Bipolar I Disorder
ALKS 3831 is composed of samidorphan, a mu-opioid receptor antagonist, which is co-formulated with the established antipsychotic agent, olanzapine, in a single bilayer tablet.
Understanding the Underlying Neurobiology Behind Group Differences in Cortical Thickness Across Psychiatric Disorders
This study highlights the importance of transdiagnostic approaches to psychiatry.
Gamma Transcranial Alternating Current Stimulation and Mood, Cognition in Major Depressive Disorder
Patients received 40 Hz gamma tACS to provide data on the use of varying stimulation periods.
Insomnia and Other Sleep-Wake Disorders
Types and characteristics of common sleep-wake disorders.
ADHD Treatments
Attention Deficit Hyperactivity Disorder (ADHD) treatment medications comparative chart.
Cognition Kit DSST App Validated for Measuring Major Depressive Disorder
Researchers conducted a study to evaluate the validity of, and satisfaction with, the Cognition KIT DSST mobile app in patients with major depressive disorder.
Simple Coping Behaviors Linked to Reduced Anxiety, Depression During COVID-19
Simple coping behaviors may protect against anxiety and depressive symptoms during the COVID-19 pandemic and lockdown.
History of Epilepsy Increases Pediatric Self-Injurious Behavior Risk
Children, adolescents, and young adults have greater risk of self-injurious behavior and suicide ideation if they have a childhood history of epilepsy.
Pimavanserin sNDA Under Review for Dementia-Related Psychosis
The FDA has accepted for filing the supplemental New Drug Application for pimavanserin for the treatment of hallucinations and delusions associated with dementia-related psychosis.
-
Loading...
-
Loading...
Next post in Alzheimer's Disease and Dementia
